Participate in Research or Clinical Trials | Boston Medical Center
doctor Find a doctor
OR
You are here

Participate in Research or Clinical Trials

For general information about participating in research, see http://www.bumc.bu.edu/ohra/ and https://www.bmc.org/research-operations/participate-research.

If you have any questions or do not see the study you are interested in, please contact the Clinical Trial Office at [email protected]

Project Title Link Principal Investigator Department Section Study Team Contact E-mail Study Team Contact Phone
Long-term effects of semaglutide on diabetic retinopathy in subjects with type 2 diabetes (FOCUS)   Devin Steenkamp Medicine Endocrinology and Diabetes   617-414-2935
PREcision Event Monitoring for PatienTs with Heart Failure using HeartLogic (PREEMPT-HF)   Kevin Monahan Medicine Cardiology   617-638-8718
RABIT(Rapid Bacterial Identification (RABIT) Study) N/A Nina Lin Medicine Infectious diseases   617-414-4170
Characterization of Systemic and Local Immune Responses to Chlamydia Antigens in Women to support Vaccine Antigen Selection N/A Nina Lin Medicine Infectious diseases   617-414-7719
The Effects of Opioid Use on HIV-1 Reservoir Dynamics: the Opioids, HIV, and Translation (OPHION) Study N/A Nina Lin Medicine Infectious diseases   617-414-3511
HIV Aging of Immune Function N/A Nina Lin Medicine Infectious diseases   617-414-7719
SELECT - Semaglutide effects on cardiovascular outcomes in people with overweight or obesity   Caroline Apovian Medicine Endocrinology, Diabetes and Nutrition   617-414-2935
Mylan GAZELLE Trial: MYL-1601D-3001 - A Randomized, Multicenter, Open-Label, Parallel-Group Clinical Study Comparing the Safety and Efficacy of MYL-1601D with NovoLog in Type 1 Diabetes Mellitus Patients   Devin Steenkamp Medicine Endocrinology, Diabetes and Nutrition   617-414-2935
SWITCH Pro: A randomised, cross-over, open-label, multi-centre trial comparing the effect of insulin degludec and insulin glargine 100U/mL, with or without OADs in subjects with type 2 diabetes using flash glucose monitoring   Devin Steenkamp Medicine Endocrinology, Diabetes and Nutrition   617-414-2935
Mona Lisa   Katharine White Obstetrics / Gynecology General Gynecology   617-414-5176
ANCHOR   Elizabeth Stier Obstetrics / Gynecology General Gynecology   214-412-9801
NAVIGATE-ESUS   Viken Babikian Neurology Stroke   617-353-2087
Vedolizumab IV Crohn's   Francis Farraye Medicine Gastroenterology   617-353-2087
HT-3951-201/PXL222158   Courtney Takahashi Neurology Stroke   617-353-2087
Macitentan   Elizabeth Klings Medicine Pulmonary, Allergy and Critical Care   617-353-2087
BMS-986141   Rafael Jose Romero Neurology Stroke   617-353-2087
REPLACE   Elizabeth Klings Arthritis Center N/A   617-353-2087
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY TO EVALUATE THE SAFETY AND EFFICACY OF CCX168 (ACACOPAN) IN PATIENTS WITH ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY (ANCA)-ASSOCIATED VASCULITIS TREATED CONCOMITANTLY WITH RITUXIMAB OR CYCLOPHOSPHAMIDE/AZATHIOPRINE   Paul Monach Medicine Rheumatology   617-353-2087
INTREPID   Anna Cervantes-Arslanian Neurology Stroke   617-353-2087
REACT: pRevention and trEatment of vAsospasm with ClazosenTan   Thanh Nguyen Neurology Stroke   617-353-2087
AdreView™ Myocardial Imaging for Risk Evaluation – A multicentre trial to guide ICD implantation in NYHA class II & III heart failure patients with 30%≤LVEF≤35%. ADMIRE-ICD   Robert Helm Medicine Cardiology   617-353-2087
IWALQQ-OA   Deepak Kumar Radiology N/A   617-358-3125
DIAGNOSE CTE   Robert Stern Neurology N/A   617-358-5443
Protocol H8A-MC-LZAZ   Robert Stern Alzheimers Disease Center N/A   617-414-1196
Registry of Amyloid Positive Patients for Alzheimer’s Disease Drug Research Trials (RAmP)   Robert Stern Neurology N/A   617-414-1196
Alcohol Disorder hosPital Treatment (ADOPT) Study   Richard Saitz Medicine General Internal Medicine   617-358-1433 Toll-free: 1-844-47-ADOPT
Boston Alcohol Research Collaboration on HIV/AIDS (ARCH) Cohort: The 4F Study   Richard Saitz Medicine General Internal Medicine   Local: 617-358-1498 Toll-free: 855-414-ARCH
CTN-0049 Outcomes, HCV   Margaret Sullivan Medicine Infectious Diseases   617-414-1395
OTO-104   Kenneth Grundfast Otolaryngology - Head and Neck Surgery N/A   617-414-1756
BP39207 BASMISANIL   David Henderson Psychiatry N/A   617-414-1911
Anifrolumab   Ramon Bonegio Medicine Nephrology   617-414-1968
Genentech GA30044   Ramon Bonegio Medicine Nephrology   617-414-1968
Btk inhibitor LTE   Ramon Bonegio Medicine Nephrology   617-414-1968
ALXN1210   Jean Francis Medicine Nephrology   617-414-1968
AURORA   Ramon Bonegio Medicine Nephrology   617-414-1968
APS Prevention   David Henderson Psychiatry N/A   617-414-1987
Efficacy and safety of SAR156597 in the treatment of diffuse cutaneous Systemic Sclerosis (dcSSc): A randomized, double-blind, placebo-controlled, 24-week, proof of concept study   Robert Simms Arthritis Center N/A   617-414-2507
DMF-PRO16070614   Robert Simms Medicine Rheumatology   617-414-2507
GSK, 201247   Robert Simms Medicine Rheumatology   617-414-2507
SCLERODERMA LUNG STUDY III SLS3   Robert Simms Medicine Rheumatology   617-414-2507
Rituximab   Robert Simms Medicine Pulmonary, Allergy and Critical Care   617-414-2507
Abatacept (CTLA4-Ig) for the Treatment of Relapsing, Non-Severe, Granulomatosis with Polyangiitis (Wegener's) (ABROGATE)   Paul Monach Medicine Rheumatology   617-414-2512
Smoking Cessation   Nina Lin Medicine Infectious Diseases   617-414-4170
Improving Outcomes in Neonatal Abstinence Syndrome (NAS)   Michael Silverstein Pediatrics Pediatric General   617-414-3827
TREETOP   Glenn Markenson Obstetrics / Gynecology Maternal-Fetal Medicine   617-414-5176
Double-Blind Placebo Controlled Trial of the Treatment of Chronic Laryngitis with Amitriptyline   Pieter Noordzij Otolaryngology - Head and Neck Surgery N/A   617-414-5449
Pfizer Rivipansel   Hedy Smith Medicine Hematology and Medical Oncology   617-414-5729
A Study to Compare Bone Marrow Transplantation to Standard Care in Adolescents and Young Adults with Severe Sickle Cell Disease   Lillian McMahon Medicine General Internal Medicine   617-414-5729
GBT440   Lillian McMahon Medicine General Internal Medicine   617-414-5729
An Open Label Extension Study of GBT440 Administered Orally to Patients with Sickle Cell Disease Who Have Participated in GBT440 Clinical Trials   Lillian McMahon Medicine Hematology and Medical Oncology   617-414-5729
A Phase IIb Randomized, Double-Blind, Placebo-Controlled Multi-Center Study to Assess the Safety, Tolerability, and Efficacy of Riociguat in Patients with Sickle Cell Diseases (STERIO-SCD)   Elizabeth Klings Medicine Hematology and Medical Oncology   617-414-5729
PHARMACOKINETIC PROPERTIES OF ANTIRETROVIRAL AND RELATED DRUGS DURING PREGNANCY AND POSTPARTUM (IMPAACT P1026S)   Mark Mirochnick Pediatrics Pediatric Infectious Diseases   617-414-5813
AbbVie Study - M16-123   Vishaka Sabharwal Pediatrics Pediatric Infectious Diseases   617-414-5813
PHASE I/II, MULTI-CENTER, OPEN-LABEL PHARMACOKINETIC, SAFETY, TOLERABILITY AND ANTIVIRAL ACTIVITY OF GSK1349572, A NOVEL INTEGRASE INHIBITOR, IN COMBINATION REGIMENS IN HIV-1 INFECTED INFANTS, CHILDREN AND ADOLESCENTS (IMPAACT P1093)   Stephen Pelton Pediatrics Pediatric Infectious Diseases   617-414-5813
A Prospective Randomized Trial to Assess PO versus IV Antibiotics for the Treatment of Early Post-op Wound Infection after Extremity Fractures   Paul Tornetta Orthopaedic Surgery Orthopaedic Surgery   617-414-6295
Pain - Orthopedic Trauma   Paul Tornetta Orthopaedic Surgery Orthopaedic Surgery   617-414-6295
OXYGEN   Paul Tornetta Orthopaedic Surgery Orthopaedic Surgery   617-414-6295
I.M.P.R.E.S.S   Paul Tornetta Orthopaedic Surgery Orthopaedic Surgery   617-414-6295
Best Endovasc vs Best Surg Thera   Jeffrey Kalish Surgery Vascular and Endovascular Surgery   617-414-6832
The Impact of Diabetes on REvascularization in BEST-CLI (TIDE)   Jeffrey Kalish Surgery Vascular and Endovascular Surgery   617-414-6832
PRESERVE   Jeffrey Kalish Surgery Vascular and Endovascular Surgery   617-414-6832
Study of SR vs SAbR in NSCLC   Kei Suzuki Surgery Thoracic Surgery   617-414-6832
Ranger   Alik Farber Surgery Vascular and Endovascular Surgery   617-414-6832
Iodixanol   Jeffrey Siracuse Surgery Vascular and Endovascular Surgery   617-414-6832
VasQ arteriovenous fistula   Alik Farber Surgery Vascular and Endovascular Surgery   617-414-6832
PICO- Lower Extremity Bypass   Jeffrey Siracuse Surgery Vascular and Endovascular Surgery   617-414-6832
Dose-response Relationship Study of S42909 on Leg Ulcer Healing   Alik Farber Surgery Vascular and Endovascular Surgery   617-414-6832
NAION   Crandall Peeler Ophthalmology N/A   617-414-8804
Zoster Eye Disease Study: A multi-center, randomized, double-masked, placebo-controlled clinical trial of suppressive valacyclovir for one year in immunocompetent study participants with an episode of dendriform epithelial keratitis, stromal keratitis, endothelial keratitis, and/or iritis due to Herpes Zoster Ophthalmicus (HZO) in the year prior to enrollment. (ZEDS)   Hyunjoo Lee Ophthalmology N/A   617-414-8804
IXT5   Stephen Christiansen Ophthalmology N/A   617-414-8805
AMC 092: A multicenter observational and feasibility study of excision of superficially invasive squamous cell carcinoma (SISCCA) of the anal canal and perianus in HIV-infected persons   Elizabeth Stier Obstetrics / Gynecology General Gynecology   617-608-7020
Janssen: Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in AmbulatoryCancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (RIVA)   John Sloan Medicine Hematology and Medical Oncology   617-638-4178
Riociguat in HIV patients   Elizabeth Klings Pulmonary Center N/A   617-638-4344
A Phase II Multi-Center Study of High-Dose Cyclophosphamide and Antithymocyte Globulin Followed by Autologous Hematopoietic Cell Transplantation with Post Transplant Maintenance for the Treatment of Systemic Sclerosis   Robert Simms Medicine Rheumatology   617-638-4475
Triton Study   Elizabeth Klings Medicine Rheumatology   617-638-4475
RANGER STudy   Elizabeth Klings Medicine Rheumatology   617-638-4475
Tafamidis Meglumine   John Berk Medicine Amyloid Research and Training Program   617-638-4591
TOL-001   John Berk Amyloidosis Center N/A   617-638-4591
An open label, multicenter study evaluating the Safety and Imaging Characteristics of a new PET Scan Test in Healthly Volunteers, Subjects with Mild Cognitive Impairment and Subjects with Alzheimer's Disease Dementia   Robert Stern Alzheimers Disease Center N/A   617-638-5368
Follow-up Avid PET Scan Study   Robert Stern Neurology N/A   617-638-5368
ARAMIS-A randomized multicenter study for isolated skin vasculitis   Paul Monach Medicine Rheumatology   617-638-5383
CUTIS-Clinical transcriptomics in systemic vasculitis   Christina Lam Medicine Rheumatology   617-638-5383
BRAVOS   Robert Simms Medicine Rheumatology   617-638-5383
Lenabasum   Robert Simms Medicine Rheumatology   617-638-5383
The LEARN Study   Robert Stern Neurology N/A   617-638-5670
Daybreak   Robert Stern Neurology N/A   617-638-5670
ADNI-3   Ronald Killiany Neurology N/A   617-638-5670
Early Study   Robert Stern Neurology N/A   617-638-5670
Dexamethasone Plus MLN9708   Vaishali Sanchorawala Medicine Hematology and Medical Oncology   617-638-6521
SWOG #S1207: Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients with High-Risk, Hormone Receptor-Positive and HER2/neu Negative Breast Cancer   Lauren Oshry Cancer Care Center N/A   617-638-6521
NRG #HN001   Minh-Tam Truong Medicine Hematology and Medical Oncology   617-638-6521
Pembrolizumab (MK-3475)   Kevan Hartshorn Cancer Care Center N/A   617-638-6521
LCCC 1637: Brentuximab Vedotin with Cyclophosphamide, Doxorubicin, Etoposide, and Prednisone (BV-CHEP) for the treatment of Adult T-Cell Leukemia/Lymphoma: A Phase II Trial of the Rare Lymphoma Working Group   Mark Sloan Medicine Hematology and Medical Oncology   617-638-6521
DALF 1016: A Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Two Dose Strengths of Dalfampridine Extended Release Tablets for Treatment of Stable Walking Deficits in Post-Ischemic Stroke   Brigid Dwyer Neurology Stroke   617-638-6527
W1239335   Sharmeel Wasan Medicine Gastroenterology   617-638-6527
Fecal Microbiota Therapy (FMT)   Francis Farraye Medicine Gastroenterology   617-638-6527
Oral RPC1063, Phase 3, Multi, Rando, Double Blind, of Oral RPC1063   Francis Farraye Medicine Gastroenterology   617-638-6527
The Regenerate Study 747-303   Michelle Long Medicine Gastroenterology   617-638-6527
A Phase 3, Multi, OLE trial of Oral RPC0163   Francis Farraye Medicine Gastroenterology   617-638-6527
GED-0301   Francis Farraye Medicine Medicine   617-638-6527
Vedolizumab   Sharmeel Wasan Medicine Gastroenterology   617-638-6527
Dose Finding Study in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)   Osamu Sakai Radiology N/A   617-638-6591
IDEAS Study     Medicine Amyloid Research and Training Program   617-638-6591
CVT009   Marie-Helene Saint-Hilaire Neurology N/A   617-638-7745
Parkinson's Progression Markers   Marie-Helene Saint-Hilaire Neurology N/A   617-638-7745
CVT-301   Marie-Helene Saint-Hilaire Neurology N/A   617-638-7745
Intec DD Study   Marie-Helene Saint-Hilaire Neurology N/A   617-638-7745
Intec OLE Study   Marie-Helene Saint-Hilaire Neurology N/A   617-638-7745
SURE-PD3   Marie-Helene Saint-Hilaire Neurology N/A   617-638-7745
228PD201   Marie-Helene Saint-Hilaire Neurology N/A   617-638-7745
XC-8998 for Essential Tremor   Okeanis Vaou Neurology N/A   617-638-7747
P2B   Marie-Helene Saint-Hilaire Neurology N/A   617-638-7747
AMC #085: A Pilot Trial of AVD and Brentuximab Vedotin (SGN-35) in the treatment of stage II-IV HIV-associated Hodgkin Lymphoma   Mark Sloan Medicine Hematology and Medical Oncology   617-638-8213
SWOG #S1320   Adam Lerner Medicine Hematology and Medical Oncology   617-638-8213
NRG #GI001: Randomized Phase III Study of Focal Radiation Therapy for Unresectable, Localized Intrahepatic Cholangiocarcinoma     Cancer Care Center N/A   617-638-8213
EA5142: Adjuvant Nivolumab in Resected Lung Cancers (ANVIL) - A Randomized Phase III Study of Nivolumab After Surgical Resection and Adjuvant Chemotherapy in Non-Small Cell Lung Cancers.   Peter Everett Medicine Hematology and Medical Oncology   617-638-8213
A021501 - Preoperative Extended Chemotherapy Vs. Chemotherapy Plus Hypofractioned Radiation Therapy for Borderline Resectable Adenocarcinoma of the Head of the Pancreas   Kevan Hartshorn Medicine Hematology and Medical Oncology   617-638-8213
S1605 - Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer   Gretchen Gignac Medicine Hematology and Medical Oncology   617-638-8213
S1418 - A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer with >/= 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN+) after Neoadjuvant Chemotherapy   Lauren Oshry Medicine Hematology and Medical Oncology   617-638-8213
EA8143: A Phase 3 Randomized Study Comparing Perioperative Nivolumab vs. Observation in Patients with Localized Renal Cell Carcinoma Undergoing Nephrectomy (PROSPER RCC)   Gretchen Gignac Medicine Hematology and Medical Oncology   617-638-8213
GU002 - PHASE II-III TRIAL OF ADJUVANT RADIOTHERAPY AND ANDROGEN DEPRIVATION FOLLOWING RADICAL PROSTATECTOMY WITH OR WITHOUT ADJUVANT DOCETAXEL   Gretchen Gignac Medicine Hematology and Medical Oncology   617-638-8213
NRG-LU002 - Maintenance Systemic Therapy Versus Consolidative Stereotactic Body Radiation Therapy (SBRT) Plus Maintenance Systemic Therapy For Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial   Marjory Charlot Medicine Hematology and Medical Oncology   617-638-8213
A031501 - PHASE III RANDOMIZED ADJUVANT STUDY OF MK-3475 (PEMBROLIZUMAB) IN MUSCLE INVASIVE AND LOCALLY ADVANCED UROTHELIAL CARCINOMA (AMBASSADOR) VERSUS OBSERVATION   Gretchen Gignac Medicine Hematology and Medical Oncology   617-638-8213
NRG-HN004: Randomized Phase II/III Trial of Radiotherapy with Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy with Concurrent Cetuximab in Patients with Stage III-IVB Head and Neck Cancer with a Contraindication to Cisplatin: Safety Lead-In Portion   Minh-Tam Truong Medicine Hematology and Medical Oncology   617-638-8213
BMS- CA2099KD   Gretchen Gignac Cancer Care Center N/A   617-638-8213
A021602 - Cabozantinib vs Placebo for NETs   Matthew H Kulke Cancer Care Center N/A   617-638-8213
Merck 671: A Phase III, Randomized, Double-blind Trial of Platinum Doublet Chemotherapy +/-Pembrolizumab (MK-3475) as Neoadjuvant/Adjuvant Therapy for Participants with Resectable Stage IIB or IIIA Non-small Cell Lung Cancer (NSCLC) (KEYNOTE-671)   Peter Everett Cancer Care Center N/A   617-638-8213
RTOG-3507: A randomized phase II study of Pembrolizumab(Keytruda®) plus Stereotactic Re-irradiation versus SBRT alone for Locoregionally recurrent or second primary head and neck carcinoma.   Michael Dyer Cancer Care Center N/A   617-638-8213
DARA-MMY3019: A Phase 3 Study Comparing Daratumumab, VELCADE (bortezomib), Lenalidomide, and Dexamethasone (D-VRd) with VELCADE, Lenalidomide, and Dexamethasone (VRd) in Subjects with Untreated Multiple Myeloma and for Whom Hematopoietic Stem Cell Transplant is Not Planned as Initial Therapy.   Vaishali Sanchorawala Cancer Care Center N/A   617-638-8213
Naloxone Hydrochloride for pruritus   Adam Lerner Cancer Care Center N/A   617-638-8213
NRG-GU003   Ariel Hirsch Radiation Oncology N/A   617-638-8213
Merck 598   Peter Everett Cancer Care Center N/A   617-638-8213
S1702   Vaishali Sanchorawala Medicine Hematology and Medical Oncology   617-638-8213
RTOG #R0534: A Phase III Trial of Short Term Androgen Deprivation with Pelvic Lymph Node or Prostate Bed Only Radiotherapy (SPPORT) in Prostate Cancer Patients with a Rising PSA After Radical Prostatectomy   Ariel Hirsch Radiation Oncology N/A   617-638-8260
RTOG #R0920: A PHASE III STUDY OF POSTOPERATIVE RADIATION THERAPY (IMRT) +/- CETUXIMAB FOR LOCALLY-ADVANCED RESECTED HEAD AND NECK CANCER   Minh-Tam Truong Radiation Oncology N/A   617-638-8260
FEASIBILITY/OUTCOMES STUDY OF HYPOFRACTIONATED STEREOTACTIC BODY RADIATION THERAPY AS A BOOST TO THE PROSTATE FOR TREATMENT OF LOCALIZED, NON-METASTATIC, HIGH RISK PROSTATE CANCER   Ariel Hirsch Radiation Oncology N/A   617-638-8260
CTSU #E1412: Randomized Phase II Open Label Study of Lenalidomide R-CHOP (R2CHOP) vs RCHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone) in Patients with Newly Diagnosed Diffuse Large B Cell Lymphoma   John Sloan Medicine Hematology and Medical Oncology   617-638-8260
A011401 - RANDOMIZED PHASE III TRIAL EVALUATING THE ROLE OF WEIGHT LOSS IN ADJUVANT TREATMENT OF OVERWEIGHT AND OBESE WOMEN WITH EARLY BREAST CANCER   Lauren Oshry Medicine Hematology and Medical Oncology   617-638-8260
A011202   Michael Cassidy Cancer Care Center N/A   617-638-8260
NRG #BN001: Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy versus Conventional Photon Irradiation with Concomitant and Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma   Minh-Tam Truong Cancer Care Center N/A   617-638-8261
Study Title: SWOG #S1500: A Randomized, Phase II Efficacy Assessment of Multiple MET Kinase Inhibitors (Cabozantinib [NSC #761968], Crizotinib [NSC #749005], Savolitinib [NSC #785348], and Sunitinib [NSC #736511]) in Metastatic Papillary Renal Carcinoma (PAPMET)   Gretchen Gignac Cancer Care Center N/A   617-638-8261
CTSU #A081105: Randomized Double Blind Placebo Controlled Study of Erlotinib or Placebo in Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)   Peter Everett Cancer Care Center N/A   617-638-8261
DFCI- Adjuvant nivolumab and lirilumab in patients with relapsed, resectable squamous cell carcinoma of the head and neck   Peter Everett Cancer Care Center N/A   617-638-8261
SWOG #S1400   Peter Everett Cancer Care Center N/A   617-638-8261
Evomela   Shayna Sarosiek Cancer Care Center N/A   617-638-8274
Proteon   Jeffrey Siracuse Surgery Vascular and Endovascular Surgery   617-638-8622
Primatrix   Hau Pham Surgery Podiatry   617-638-8622
ORI-16-003   Hau Pham Surgery Podiatry   617-638-8622
Topstone   Hau Pham Surgery Podiatry   617-638-8622
Cx601 Investigator’s Brochure. Therapy with expanded human allogeneic adult stem cells extracted from adipose tissue.   Jason Hall Surgery Colon and Rectal Surgery   617-638-8622
ISCHEMIA   Claudia Hochberg Medicine Cardiology   617-638-8716
Absorb™ BVS   Alice Jacobs Medicine Cardiology   617-638-8716
Decamp 2   Ehab Billatos Medicine Computational Biomedicine   617-638-8716
Multicenter, randomized, double blind, placebo controlled, phase 2 study evaluating the safety and efficacy of different doses of IW-1973 over 12 weeks in patients with heart failure with preserved ejection fraction   Flora Sam Medicine Cardiology   617-638-8716
Effi and Safety of NEOD001   Vaishali Sanchorawala Medicine Hematology and Medical Oncology   781-207-7591
Dara Janssen   Vaishali Sanchorawala Cancer Care Center N/A   781-207-7591
MirenaE   Katharine White Obstetrics / Gynecology General Gynecology   617-414-7304
OR